About
Advancing Cell Therapy Around the World
Call Today: (800) 231-0407
Advancing Cell Therapy Around the World
Cell Surgical Network is an international team of physicians committed to advancing personal cell therapy for their patients. There are over 500 doctors currently participating with CSN, located across 25 different countries, including the USA, Canada, South Korea, Japan, China, the UAE, Turkey, Australia, South Africa and more.
CSN members work with autologous adipose derived stem cells, known as Stromal Vascular Fraction (SVF). SVF contains mesenchymal stem cells, hematopoietic stem cells, pericytes, and pre-adipocytes, all of which are progenitor cells. When these cells are placed in injured areas, they can pick up local cytokine signals to differentiate, transfer healthy mitochondria, or share cytokine signals, all of which can promote healing naturally, using a patient’s own personal DNA.
CSN’s technology relies on what’s natural in the human body: reparative stem cells, with our patients’ own DNA. We focus on adipose derived stem cells that are largely sequestered from the rest of the body, are 500 to 1,000 times greater in number than compared to bone marrow derived stem cells and are a very young cell. Since adipose has a life span of 7-10 years, adipose derived stem cells generally have very long telomeres (the age determinant of a cell), and thus the adipose derived stem cells from a 70 or 80 year old are actually very young and robust cells that can be used for self-healing.
Personal cell therapy will one day be a tool in every physician’s tool belt. Stem cells can be used to promote healing in injured tissue and are immunomodulatory. Currently, there is an abundance of studies in the orthopedic, pain management, neurologic, and urologic fields. However, increased research is coming from the fields of cardiology, rheumatology, pulmonology and others, as more specialists learn how stem cells can be applied in their fields.
Healing. In medicine, the goal is to heal our patients. Stem cells represent a paradigm shift from traditional medicine which looks to stabilize a condition enough that the body can naturally recruit it’s own native stem cell or white blood cell population for self-repair. If we can isolate dormant stem cells in adipose tissue and make them bio-available to our patients, we give them an opportunity to expedite the healing process, something that wasn’t previously possible in medicine.
Advancing Cell Therapy Around the World
The CSN Time Machine is utilized by hundreds of clinics across the country and around the world and to date has been used in tens of thousands of personal cell therapy cases. The Time Machine 3.0 brings a new level of sophistication to the clinical process, providing doctors with a surgically closed system that automatically isolates stromal vascular fraction without the headache of manual intervention, while always prioritizing cell count and viability. Watch a 2-minute presentation on our equipment here.
Advancing Cell Therapy Around the World
Dr. Berman, the 2010 President of the American Academy of Cosmetic Surgery, has been in private practice in the West Los Angeles area since 1983 and has been practicing in the Desert Area since 2003. Dr. Berman graduated from UCLA prior to completing medical school at the Chicago Medical School. He is a clinical instructor in facial plastic surgery through the University of Southern California. Dr. Berman is a Diplomat with the American Board of Cosmetic Surgery and the American Board of Otolaryngology (Head and Neck Surgery). He is a Fellow of the American College of Surgeons. Los Angeles Magazine has named him one of the Top Doctors in Southern California. Dr. Berman is well known for his work with stem cell / fat grafting to restore three-dimensional volume to the agin face. Fat grafting has led to his work with adipose derived stem cells. He is also known as a pioneer in the use of Gore-Tex materials for cosmetic surgery. He holds a patent on an e-PTFE breast implant device, the Pocket Protector, used to improve breast augmentation surgery. He has also authored a novel – Substance of Abuse – a controversial thriller that suggests a solution to the war on drugs.
Dr. Lander is a Board-Certified Surgeon. He was born in Los Angeles, California. He graduated Magna Cum Laude and Phi Beta Kappa from Occidental College with a Distinction in Biochemistry, then attended medical school at the University of California, Irvine. For six years after medical school, Dr. Lander studied General Surgery and then Urologic Surgery at the University of California, Irvine. He was a Clinical Assistant Professor of Urology at the same institution while in practice in Orange County for five years. During that time he was active in teaching residents and doing research. Dr. Lander has been elected as a Fellow of the American College of Surgeons.
He has served as Chief of Urology at Eisenhower Medical Center and Chief of Surgery at John F. Kennedy Hospital. He is also an Expert Reviewer in Urology for the California Medical Board. After being on staff at Eisenhower Medical Center for eighteen years, Dr. Lander began clinical research on liposome encapsulated agents for the treatment of interstitial cystitis, publishing an original article on this topic in July 2014. In addition to interstitial cystitis, Dr. Lander has a special interest in hormone replacement and regenerative urology for Peyronie’s Disease and erectile dysfunction.
Dr. Grogan is a practicing orthopedic surgeon at Pacific Coast Sports Medicine in Los Angeles. Dr. Grogan graduated cum laude from Princeton University with a degree in Biology and received his medical degree from the University of Cincinnati, College of Medicine. Dr. Grogan’s orthopedic training has included an orthopedic residency at UCLA, plus several fellowships in pediatric orthopedics, trauma, and NIH sponsored joint replacement surgery. Following his orthopedic training, he returned to Los Angeles, and spent six years at Shriner’s Hospital for Crippled Children, where he served as Assistant Chief from 1996-97.
Dr. See, is a Board Certified Internist, a Fellow of the American College of Cardiology, and a pioneer of Interventional Cardiology. His group founded the teaching program of Interventional Cardiology at the UC Irvine School of Medicine. He is currently the elected Co-President of his alma mater, the UC Irvine College of Medicine Alumni Association. This was followed by a Residency and Cardiology Fellowship at the Huntington Memorial Hospital, and a Research Fellowship in Medicine at the Peter Bent Brigham Harvard Medical School in Boston. Dr. See has served as Chief of Staff, Vice-Chief of Staff, Chief of Medicine, Chief of Cardiology, Cath Lab Director and other elected Medical Staff positions at Southern California and Nevada Hospitals.
Dr. Braslow is an orthopedic surgeon who consults at the California Stem Cell Treatment Center in Rancho Mirage, California. He practiced at the John F. Kennedy Memorial Hospital for over a decade, where he was the medical director of the hospital’s Arthritis Institute. He specializes in arthritis treatment, particularly knee replacements, and has a breadth of experience in the development and design of joint replacements. Dr. Braslow’s extensive experience in joint replacement includes designing and developing a number of products, including the Implex Hedrocel Unicompartmental Knee Replacement for Implex Corporation, the Genus Unicompartmental Knee Replacement for BioMet, and the Knee Ligament Surgery Instrumentation and Reconstruction Techniques for the De Puy Corp. and Osteonics. Dr. Braslow has extensive experience treating over one thousand patients with autologous stem cells for orthopedic conditions.
Dr. Lee is a Board Certified Plastic Surgeon in practice in Seoul, South Korea. While noted for his surgical skills, he is also a renowned scientist and inventor. He is often referred to as “the Tony Stark, or Ironman” of medicine. Lee has numerous patented inventions to his name. Most remarkable is perhaps his invention of “Lipokit”, a system used by The Cell Surgical Network® (CSN) to produce Stromal Vascular Fraction (SVF). Under his helm, he has developed arguably the best, most affordable and user friendly surgical system for producing SVF. Currently he is developing an innovative cell culturing system, which promises to greatly advance the field of regenerative medicine and cell therapy.
Dr. O’Brien is the Director of Pacific Coast Sports Medicine in Los Angeles, and is a California Board Certified Orthopedic Surgeon. He is a member of the American Academy of Orthopedic Surgeons. Dr. O’Brien received his BS and MD from the University of Kansas, and has completed five different fellowships in sports medicine in the following locations: Paris, Switzerland, Canada, New York, and Ohio. Dr. O’Brien has written multiple publications contributing to orthopedic literature, including several textbook chapters.
Dr. Feller completed his undergraduate training in metallurgical engineering and materials science at the University of Notre Dame graduating cum laude. He then attended the Ohio State University School of Medicine graduating summa cum laude before completing postgraduate medical training at the Stanford University School of Medicine, which culminated in Diagnostic Radiology board certification. Following fellowship training in orthopedics and body MRI, Dr. Feller served in the US Air Force as the Chief of MRI at the David Grant USAF Medical Center; a position he maintained for four years. Dr. Feller lectures internationally and is a pioneer of SVF therapy for orthopedic and spine problems.
Dr. Duma is the Head of the Division of Radiosurgery in the Department of Neurosurgery at the University of California, Irvine, School of Medicine. His numerous accolades include: Medical Director, Hoag/UCI Gamma Knife Program, Vice-Chairman, Department of Neurosurgery, and prior Chairman, Department of Neurosurgery Hoag Memorial Hospital Presbyterian. He trained at the State University of New York at Stonybrook, completed his Neurosurgery residency at Georgetown in Washington, DC, and achieved his Fellowship in Gamma Knife Radiosurgery from the University of Pittsburgh. Since 2000, Dr. Duma has been Chairman of the Board of DatCard Systems, Inc. He has authored of over 60 publications and 8 book chapters, and is involved in cutting edge research deploying SVF into the central nervous system.
Advancing Cell Therapy Around the World
Advancing Cell Therapy Around the World
Advancing Cell Therapy Around the World